Glioblastoma
Showing NaN - NaN of 28
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)
Active, not recruiting
- Glioblastoma
- Recurrent Glioblastoma
-
Boston, Massachusetts
- +3 more
Jan 13, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose
Recruiting
- Advanced Malignant Solid Neoplasm
- +5 more
- RSC-1255 Dose Escalation
- RSC-1255 Dose Expansion
-
Los Angeles, California
- +5 more
Oct 24, 2022
Glioblastoma Trial in Canada, China, United States (drug, other, radiation)
Active, not recruiting
- Glioblastoma
- Enzastaurin Hydrochloride
- +3 more
-
Birmingham, Alabama
- +62 more
Oct 11, 2022
Glioblastoma Trial in United States (biological, radiation, drug)
Active, not recruiting
- Glioblastoma
- INO-5401
- +4 more
-
Duarte, California
- +20 more
Aug 8, 2022
Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)
Recruiting
- Glioblastoma
- Adult-type Diffuse Gliomas
-
Beverly Hills, California
- +83 more
Jul 25, 2022
Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)
Not yet recruiting
- Glioblastoma Multiforme
- Glioblastoma
- IGV-001 Cell Immunotherapy
- +3 more
-
Newark, Delaware
- +22 more
Jun 24, 2022
Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)
Active, not recruiting
- Glioblastoma Multiforme
- +6 more
- Dendritic cell immunotherapy
-
Birmingham, Alabama
- +85 more
May 12, 2022
Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)
Active, not recruiting
- Glioblastoma
- DSP-7888 Dosing Emulsion
- Bevacizumab
-
Birmingham, Alabama
- +60 more
Apr 4, 2022
Glioblastoma Trial in Philadelphia (Radation Therapy)
Recruiting
- Glioblastoma
- Radation Therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 31, 2022
Glioblastoma Trial in Philadelphia (18F-FluorThanatrace)
Recruiting
- Glioblastoma
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 21, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)
Recruiting
- Glioblastoma
- +2 more
- Niraparib
- +2 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jul 16, 2021
Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,
Recruiting
- Glioblastoma
- +2 more
- Intensity-Modulated Radiation Therapy
- Quality-of-Life
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Glioblastoma Trial in Philadelphia (drug, radiation, device, procedure)
Recruiting
- Glioblastoma
- Temozolomide
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)
Terminated
- Glioblastoma
- +2 more
- Bevacizumab
- TTFields Therapy
-
La Jolla, California
- +10 more
May 12, 2021
Glioblastoma, Malignant Solid Tumor Trial in Philadelphia (Biospecimen Collection)
Recruiting
- Glioblastoma
- Malignant Solid Neoplasm
- Biospecimen Collection
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Mar 26, 2021
Glioblastoma Trial in Philadelphia (CART-EGFRvIII T cells, Pembrolizumab)
Completed
- Glioblastoma
- CART-EGFRvIII T cells
- Pembrolizumab
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 2, 2021
Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,
Completed
- Glioblastoma
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +6 more
-
Mobile, Alabama
- +329 more
Jul 22, 2019
Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,
Completed
- Glioblastoma
- +4 more
- Rindopepimut (CDX-110) with GM-CSF
- +2 more
-
Birmingham, Alabama
- +222 more
Jan 11, 2018